A commentary on outcomes with liquid biopsy to determine the epidermal growth factor receptor mutation status in poor performance status, biopsy-ineligible, advanced non-small cell lung cancer patients

Document Type

Letter to the Editor

Publication Title

Cancer Research, Statistics, and Treatment

First Page

141

Last Page

142

DOI

10.4103/CRST.CRST_133_19

Publication Date

1-1-2020

This document is currently not available here.

Share

COinS